Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

More articles from Educational Exhibit Posters-Oncology

  • You have access
    18F-FDG PET/CT findings of perineural involvement in head and neck malignancies
    Dimitrios Kalkanis, Fabio Paes, Osama Gomaa and Aldo Serafini
    Journal of Nuclear Medicine May 1, 2010, 51 (supplement 2) 1092;
  • You have access
    Imaging breast cancer patients with brachial plexus syndrome
    Patrick Peller, Robert Murphy and Rathan Subramaniam
    Journal of Nuclear Medicine May 1, 2010, 51 (supplement 2) 1069;
  • You have access
    Patient specific clinical dosimetry in radioiodine therapy for thyroid cancer: Refining approaches to treatment of patients
    Arif Sheikh, Richard Kowalsky, Joshua Etten, Allen Chau, Cynthia Janice, Amir Khandani, William McCartney and Marija Ivanovic
    Journal of Nuclear Medicine May 1, 2010, 51 (supplement 2) 1089;
  • You have access
    A review of I-131 induced sialoadenitis in patients with well differentiated thyroid cancer - Clinical presentation, frequency, prevention, management, and complications
    Shyam Chennupati, Aiysha Ansari, Kalpna Prasad, Gauri Khorjekar, Kanchan Kulkarni and Douglas Van Nostrand
    Journal of Nuclear Medicine May 1, 2010, 51 (supplement 2) 1082;
  • You have access
    FDG PET/CT manifestations of hematopoietic malignancies of the breast
    Daniel Ginat and Savita Puri
    Journal of Nuclear Medicine May 1, 2010, 51 (supplement 2) 1083;
  • You have access
    PET-CT case examples illustrating revisions of the new lung cancer staging system: What it means to physicians and patients
    Scott Adams and William Erdman
    Journal of Nuclear Medicine May 1, 2010, 51 (supplement 2) 1086;
  • You have access
    Early response assessment of chemotherapy in patients with NHL using FDG-PET
    Hongbiao Liu, Jungmin Han and Hani Abdel-Nabi
    Journal of Nuclear Medicine May 1, 2010, 51 (supplement 2) 1077;
  • You have access
    Muscle metastases and their appearance on PET/CT imaging
    S. Johnson, Karen Holdeman, Jordan Hankins and Homeira Zahiri
    Journal of Nuclear Medicine May 1, 2010, 51 (supplement 2) 1076;
  • You have access
    FDG PET/CT findings of rare hepatobiliary/liver tumors
    Kentaro Takanami, Tomomichi Hiraide, Tomohiro Kaneta and Shoki Takahashi
    Journal of Nuclear Medicine May 1, 2010, 51 (supplement 2) 1078;
  • You have access
    Preclinical evaluation of [F-18]-2’-fluoro-5-methyl-1-beta-D-arabinofuranosyluracil ([F-18]-FMAU) PET in prostate cancer
    Hossein Jadvar, Zibo Li and Peter Conti
    Journal of Nuclear Medicine May 1, 2010, 51 (supplement 2) 1088;

Pages

  • Next
  • 1
  • 2
  • 3
SNMMI

© 2025 SNMMI

Powered by HighWire